[HTML][HTML] Human papillomavirus circulating tumor DNA assays as a mechanism for head and neck cancer equity in rural regions of the United States
M Windon, C Haring - Frontiers in Oncology, 2024 - ncbi.nlm.nih.gov
The rates of human papillomavirus-positive oropharyngeal cancer (HPV-OPC) are rising
worldwide and in the United States, particularly in rural regions including Appalachia. Rural …
worldwide and in the United States, particularly in rural regions including Appalachia. Rural …
Circulating Tumor DNA in Human Papillomavirus–Mediated Oropharynx Cancer: Leveraging Early Data to Inform Future Directions
MEH Neal, HM Walline, CT Haring - The Cancer Journal, 2023 - journals.lww.com
Circulating tumor DNA (ctDNA) has become an area of intense study in many solid
malignancies including head and neck cancer. This is of particular interest for human …
malignancies including head and neck cancer. This is of particular interest for human …
Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma
JS Lewis Jr, S Naegele, V Efthymiou… - American Journal of …, 2024 - academic.oup.com
Objectives In this feasibility study, we explored the combined use of circulating tumor human
papillomavirus (HPV) DNA (ctHPVDNA) and HPV serology as diagnostic tests for HPV …
papillomavirus (HPV) DNA (ctHPVDNA) and HPV serology as diagnostic tests for HPV …
[引用][C] Emerging role of blood‐based biomarker testing in HPV‐mediated head and neck squamous cell carcinoma
CT Haring, JW Rocco - Cancer Cytopathology, 2024 - Wiley Online Library
The incidence of head and neck squamous cell carcinoma (HNSCC) related to human
papillomavirus (HPV) has increased dramatically and is expected to continue to rise despite …
papillomavirus (HPV) has increased dramatically and is expected to continue to rise despite …